The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A phase 2 study evaluating response and biomarkers in patients with microsatellite stable (MSS) advanced colorectal cancer (CRC) treated with nivolumab/relatlimab.
 
Eric Christenson
Consulting or Advisory Role - Seres Therapeutics
Research Funding - Haystack Oncology; Pfizer
Other Relationship - Natera
(OPTIONAL) Uncompensated Relationships - Brenus Pharma
 
Jennifer N. Durham
Employment - AstraZeneca/MedImmune (I)
Stock and Other Ownership Interests - AstraZeneca/MedImmune (I)
 
Madelena Brancati
No Relationships to Disclose
 
Heather Davis Bruning
No Relationships to Disclose
 
Susan Petrie
No Relationships to Disclose
 
Hao Wang
No Relationships to Disclose
 
Jiayun Lu
No Relationships to Disclose
 
Katherine M. Bever
Employment - AstraZeneca (I); Personal Genome Diagnostics (I); Qiagen (I); SOPHiA Genetics (I)
Stock and Other Ownership Interests - SOPHiA Genetics (I)
Research Funding - Bristol-Myers Squibb (Inst); Merck (Inst)
 
Dan Laheru
No Relationships to Disclose
 
Ana De Jesus-Acosta
Consulting or Advisory Role - Merck
Research Funding - AstraZeneca (Inst); Merck (Inst)
 
Ross C. Donehower
No Relationships to Disclose
 
Michael J. Pishvaian
Stock and Other Ownership Interests - Perthera; Targeting Resistance in Cancer Cooperative; Tumor Board Tuesday
Consulting or Advisory Role - Astellas Pharma; AstraZeneca/MedImmune; IDEAYA Biosciences; Merck; Merus; Moderna Therapeutics; Novartis; Pfizer; Seattle Genetics/Astellas; TriSalus Life Sciences
Research Funding - Actuate Therapeutics (Inst); Amgen (Inst); Arcus Biosciences (Inst); Astellas Pharma (Inst); BioMed Valley Discoveries (Inst); Boehringer Ingelheim (Inst); Elevation Oncology (Inst); Hutchison MediPharma (Inst); IDEAYA Biosciences (Inst); MEI Pharma (Inst); Merck (Inst); Novartis (Inst); Pfizer (Inst); RenovoRx (Inst); Repare Therapeutics (Inst); Seattle Genetics/Astellas (Inst); Takeda (Inst); Tesaro (Inst); Tizona Therapeutics, Inc. (Inst)
Patents, Royalties, Other Intellectual Property - Perthera patient matching algorithm; Use patent for veliparib and FOLFOX
Travel, Accommodations, Expenses - Astellas Pharma; RenovoRx
 
Nilofer Saba Azad
Stock and Other Ownership Interests - Haystack Oncology; Irazu; Tempus
Consulting or Advisory Role - AstraZeneca; GlaxoSmithKline; Incyte; Jazz Pharmaceuticals; Jazz Pharmaceuticals; Lilly; Merck; Mirati Therapeutics; Taiho Pharmaceutical; Tempus
Speakers' Bureau - AstraZeneca
Research Funding - Agios (Inst); Array BioPharma (Inst); Astex Pharmaceuticals (Inst); AtlasMedx (Inst); Bayer (Inst); Bristol-Myers Squibb (Inst); Celgene (Inst); Debiopharm Group (Inst); EMD Serono (Inst); Genentech (Inst); Incyte (Inst); Intensity Therapeutics (Inst); Loxo/Lilly (Inst); Merck (Inst); Mirati Therapeutics (Inst); Syndax (Inst)
Travel, Accommodations, Expenses - Mirati Therapeutics
 
Qingfeng Zhu
No Relationships to Disclose
 
Nicolas Jose Llosa
No Relationships to Disclose
 
Franck Housseau
Patents, Royalties, Other Intellectual Property - PCT/US2017/056557 licensed to Mana T Bio Inc.
 
Robert Anders
No Relationships to Disclose
 
Drew M. Pardoll
Stock and Other Ownership Interests - Aduro Biotech; Compugen; Neximmune
Consulting or Advisory Role - Amgen; MedImmune; Merck; Pfizer; Sanofi
Research Funding - Aduro Biotech; Bristol-Myers Squibb; Compugen; Potenza Therapeutics
Patents, Royalties, Other Intellectual Property - Royalties on patents licensed to Aduro, BMS, Potenza, Mana T Bio Inc.
 
Dung T. Le
Honoraria - Merck
Consulting or Advisory Role - Bayer; Bristol-Myers Squibb; Catenon; G1 Therapeutics; HalioDX; Janssen; Merck; Merus NV; Nouscom; Regeneron; Tango Therapeutics; Taovtek Biotherapeutics
Research Funding - Abbvie (Inst); Aduro Biotech; Bristol-Myers Squibb; Curegenix; Medivir; Merck; Nouscom (Inst)
Patents, Royalties, Other Intellectual Property - Inventor of technology, "Microsatellite Instability as a Pharmacogenomic Marker of Therapeutic Response to Immune Checkpoint Inhibition".